S 3304 clinical trials
Also written S-3304.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How each study uses S 3304 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- S-3304
- 3
Studies by the year they started
3 studies that test it; most in 2001 (2)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses S 3304 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung CancerCompletedPhase 1/2ShionogiNCT00078390Written as S-3304
- A Phase 1 Study of S-3304 in Patients With Solid TumorsCompletedPhase 1ShionogiNCT00033215Written as S-3304
- S-3304 in Treating Patients With Advanced Solid TumorsCompletedPhase 1Roswell Park Cancer InstituteNCT00033566Written as S-3304
Codes
What other systems call S 3304 · ClinicalTrials.gg INT004813
- MeSH (NLM) C503948S 3304One source ClinicalTrials.gov
- UNII (FDA) BK459F050XS-3304Confirmed FDA, Wikidata
- Wikidata Q27274720S-3304Confirmed FDA, Wikidata
- NCI Thesaurus C2671MMP Inhibitor S-3304One source FDA
- DrugBank DB12149One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C503948 | S 3304 | One source ClinicalTrials.gov |
| UNII (FDA) | BK459F050X | S-3304 | Confirmed FDA, Wikidata |
| Wikidata | Q27274720 | S-3304 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C2671 | MMP Inhibitor S-3304 | One source FDA |
| DrugBank | DB12149 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.